» Articles » PMID: 31191232

The Inflammatory Response After Ischemic Stroke: Targeting β and β Integrins

Overview
Journal Front Neurosci
Date 2019 Jun 14
PMID 31191232
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic stroke is a leading cause of death and disability with limited therapeutic options. Resulting inflammatory mechanisms after reperfusion (removal of the thrombus) result in cytokine activation, calcium influx, and leukocytic infiltration to the area of ischemia. In particular, leukocytes migrate toward areas of inflammation by use of integrins, particularly integrins β and β. Integrins have been shown to be necessary for leukocyte adhesion and migration, and thus are of immediate interest in many inflammatory diseases, including ischemic stroke. In this review, we identify the main integrins involved in leukocytic migration following stroke (α β, αβ, αβ, and αβ) and targeted clinical therapeutic interventions.

Citing Articles

Blood-based protein biomarkers during the acute ischemic stroke treatment window: a systematic review.

Rahmig J, Chanpura A, Schultz A, Barone F, Gustafson D, Baird A Front Neurol. 2024; 15:1411307.

PMID: 39091977 PMC: 11291248. DOI: 10.3389/fneur.2024.1411307.


Hemiplegia in acute ischemic stroke: A comprehensive review of case studies and the role of intravenous thrombolysis and mechanical thrombectomy.

Carrillo Navarrete K, Chapa Gonzalez C Ibrain. 2024; 10(1):59-68.

PMID: 38682021 PMC: 11045183. DOI: 10.1002/ibra.12146.


The Relevance of Reperfusion Stroke Therapy for miR-9-3p and miR-9-5p Expression in Acute Stroke-A Preliminary Study.

Gendosz de Carrillo D, Kocikowska O, Rak M, Krzan A, Student S, Jedrzejowska-Szypulka H Int J Mol Sci. 2024; 25(5).

PMID: 38474013 PMC: 10931570. DOI: 10.3390/ijms25052766.


A myristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor peptide attenuates neutrophil outside-in β-integrin activation and signaling.

Conley H, Till R, Berglund A, Jones S, Sheats M Cell Adh Migr. 2023; 17(1):1-16.

PMID: 37439125 PMC: 10348033. DOI: 10.1080/19336918.2023.2233204.


Targeting Neutrophil β-Integrins: A Review of Relevant Resources, Tools, and Methods.

Conley H, Sheats M Biomolecules. 2023; 13(6).

PMID: 37371473 PMC: 10296028. DOI: 10.3390/biom13060892.


References
1.
Springer T, Galfre G, Secher D, Milstein C . Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol. 1979; 9(4):301-6. DOI: 10.1002/eji.1830090410. View

2.
Elkins J, Veltkamp R, Montaner J, Johnston S, Singhal A, Becker K . Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2017; 16(3):217-226. DOI: 10.1016/S1474-4422(16)30357-X. View

3.
Berkhemer O, Fransen P, Beumer D, van den Berg L, Lingsma H, Yoo A . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2014; 372(1):11-20. DOI: 10.1056/NEJMoa1411587. View

4.
Park E, Peixoto A, Imai Y, Goodarzi A, Cheng G, Carman C . Distinct roles for LFA-1 affinity regulation during T-cell adhesion, diapedesis, and interstitial migration in lymph nodes. Blood. 2009; 115(8):1572-81. PMC: 2830762. DOI: 10.1182/blood-2009-08-237917. View

5.
Hyun Y, Lefort C, Kim M . Leukocyte integrins and their ligand interactions. Immunol Res. 2009; 45(2-3):195-208. PMC: 2990789. DOI: 10.1007/s12026-009-8101-1. View